Phase II Trial of Velcade + Vorinostat in the Treatment

Project: Research project

Project Details

Description

Phase II Trial of Velcade + Vorinostat in the Treatment of High Risk MDS and Relapsed/Refractory AML
StatusFinished
Effective start/end date1/1/0812/31/13

Funding

  • MERCK AND CO INC

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.